COVID-19 Vaccine

Vaccine Information for the General Public

Anyone 5 years and older is eligible for a FREE COVID-19 vaccine. The Pfizer-BioNTech COVID-19 vaccine is approved for anyone 5 years and older, while Moderna and Johnson & Johnson are approved for those 18 years and older.

  • All Virginians are encouraged to get vaccinated to protect themselves, their loved ones, and their communities.
  • Vaccines offer the best form of protection against COVID-19.
  • Getting most Virginians vaccinated is the best way to end the pandemic and get back to normal.

Visit the Arlington County Public Health Division COVID-19 Vaccine Clinic Scheduling page for specific information and details on how to get your vaccine.

Remember, receiving the COVID-19 vaccine is just one part of the effort to reduce the spread of the virus. Even after you are vaccinated, you will still need to practice prevention steps.  

COVID-19 Vaccination Schedule for the General Population (last updated 5/20/2022)

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised is provided in a separate table after the COVID-19 Vaccination Schedule for the General Population.

 COVID-19 Vaccination Schedule for the General Population
COVID-19 Vaccines* Ages Approved Vaccination Schedule
 mRNA Vaccines:**
Pfizer-BioNTech 5-11

2-dose primary series (21 days between doses)

A single booster dose is recommended 5 or more months after the primary series

Pfizer-BioNTech (Comirnaty) 12-49

2-dose primary series (21 days between doses)

A single booster dose is recommended 5 or more months after the primary series

Pfizer-BioNTech (Comirnaty) 50 and older

2-dose primary series (21 days between doses)

2-dose booster series is recommended:

  • First booster dose is recommended 5 or more months after the primary series
  • Second booster dose is recommended using an mRNA vaccine 4 months after the first booster dose
Moderna (Spikevax) 18-49

2-dose primary series (28 days between doses)

A single booster dose is recommended 5 or more months after the primary series

Moderna (Spikevax) 50 and older

2-dose primary series (28 days between doses)

2-dose booster series is recommended:

  • First booster dose is recommended 5 or more months after the primary series
  • Second booster dose is recommended using an mRNA vaccine 4 months after the first booster dose
Anyone unable or unwilling to receive mRNA vaccine
Johnson and Johnson (Janssen)

Viral vector vaccine

18-49

1-dose primary series

A single booster dose^ is recommended 2 or more months after the primary series

^People ages 18-49 who are not moderately or severely immunocompromised and received a Johnson & Johnson (J&J) primary vaccine and J&J booster dose can get a second booster dose using an mRNA vaccine 4 months after their first J&J booster dose.

Johnson and Johnson (Janssen)

 Viral vector vaccine

50 and older

1-dose primary series

2-dose booster series is recommended:

  • First booster dose is recommended 2 or more months after the primary series
  • Second booster dose is recommended using an mRNA vaccine 4 months after the first booster dose

* CDC recommends mRNA vaccines (Pfizer and Moderna) over the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine for people aged 18 years and older. Anyone unable or unwilling to receive an mRNA vaccine can request Johnson & Johnson’s COVID-19 vaccine. You may choose which COVID-19 vaccine to receive as your primary series and as a booster dose. Talk to your healthcare provider for additional guidance.

** Some people aged 12 and older, especially males 12 to 39 years of age, may want to consult with their healthcare provider about the interval length between the first and second dose of mRNA vaccine series based on the individual patient's risk and benefit profile. (see CDC guidance for more information)

COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised (last updated 5/20/2022)

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. The Centers for Disease Control and Prevention (CDC) provides vaccination guidance for people who are moderately or severely immunocompromised. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for the General Population is provided in a separate table above the COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised.

COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised
COVID-19 Vaccines* Ages Approved Vaccination Schedule
mRNA Vaccines:**
Pfizer-BioNTech 5-11

4 Total Doses

 3-Dose Primary Series for persons 5+ years

  1. First dose Pfizer-BioNTech
  2. Second dose recommended 21 or more days after first dose
  3. Third (additional) dose recommended 28 or more days after second dose

Booster Series

4. A single booster dose recommended 5 or more months after the 3-dose primary series

Pfizer-BioNTech (Comirnaty) 12 and older 

5 Total Doses

 3-Dose Primary Series

  1. First dose Pfizer-BioNTech
  2. Second dose recommended 21 or more days after first dose
  3. Third (additional) dose recommended 28 or more days after second dose

Booster Series

4. First booster dose recommended 3 or more months after the primary series

5. Second booster dose recommended using an mRNA vaccine 4 or more months after the first booster dose

Moderna (Spikevax) 18 and older

5 Total Doses

3-Dose Primary Series

  1. First dose Moderna
  2. Second dose recommended 28 or more days after first dose
  3. Third (additional) dose recommended 28 or more days after second dose

Booster Series

4. First booster dose recommended 3 or more months after the primary series

5. Second booster dose recommended using an mRNA vaccine 4 or more months after the first booster dose

Anyone unable or unwilling to receive mRNA vaccine

Johnson and Johnson (Janssen)***

Viral vector vaccine

18 and older

4 Total Doses***

 2-Dose Primary Series

  1. First dose J&J
  2. An additional dose using an mRNA vaccine recommended 28 or more days after the first J&J dose

Booster series

3. First booster shot (preferably mRNA) recommended 2 or more months after additional dose of primary series

4. Second booster dose recommended using an mRNA vaccine 4 or more months after the first booster dose

CDC recommends mRNA vaccines (Pfizer and Moderna) over the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine for people aged 18 years and older. Anyone unable or unwilling to receive an mRNA vaccine can request Johnson & Johnson’s COVID-19 vaccine. You may choose which COVID-19 vaccine to receive as your primary series and as a booster dose. Talk to your healthcare provider for additional guidance.

** Some people aged 12 and older, especially males 12 to 39 years of age, may want to consult with their healthcare providers about the interval length between the first and second dose of mRNA vaccine series based on the individual patient's risk and benefit profile. (see CDC guidance for more information)

*** CDC provides additional details to assist recipients of Johnson and Johnson (Janssen) to complete the 4-dose regimen.  See Appendix D, Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States for more information.